Irina Pahlevanyan: Global Leaders on Courage, Trust, and the True Purpose of Fundraising
Irina Pahlevanyan, Vice President of the Executive Board and Chair of the Corporate Sustainability Commission at ICC National Committee Armenia, Executive Director at 4090 Charity Foundation, shared a post on LinkedIn:
“Some conversations remind us why we do what we do!
In this powerful exchange between Her Royal Highness Princess Dina Mired and Dr. Gevorg Tamamyan, two remarkable global leaders speak openly about the importance of asking for support when it is for the wellbeing of others.
It is a powerful reminder that fundraising is never about money itself. It is about courage, trust, and the willingness to stand between vulnerability and opportunity.
It is about opening doors for those who cannot open them alone. It is about making impact, creating chances, protecting futures, and sometimes even saving lives.
Moments like this remind me why fundraising is not just a profession, it is a mission.
By the way, if you would like to listen to the full episode, which is full of deep insights and meaningful reflections.”
Proceed to the video attached to the post.
Stay updated with Hemostasis Today.
-
Sep 9, 2026, 17:57CRISPR/Cas Gene Editing in β-Thalassemia: From Molecular Correction to Clinical Reality
-
Sep 9, 2026, 17:38Cardiovascular Health in Bleeding Disorders – EHC
-
Sep 9, 2026, 17:33Manasvi Shah: Co-Inheritance of Alpha Globin Gene Multiplication With Beta Globin Gene Abnormalities
-
Sep 9, 2026, 17:29Christina Crossette-Thambiah: One of the Largest Studies to Date in Antiphospholipid Syndrome
-
Sep 9, 2026, 17:25Alan Nurden: A miR-146a Variant Reveals a New Pathway Linking Platelet Metabolism and Thrombosis
-
Sep 9, 2026, 17:17When Is Thrombophilia Testing Appropriate and How Can the Evidence Guide Clinical Care? – ISTH
-
Sep 9, 2026, 16:07Zahra Safarzadeh: From Novel F8 Variant to Clinical Significance
-
Sep 9, 2026, 16:00Maximo Agustin Schiavone: HDL Beyond Cholesterol – Linking Lipids and Immunity
-
Sep 9, 2026, 15:56Abdul Mannan: When Antiseizure Drugs Alter DOAC Risk